Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

John Field

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Genes & Molecular Sequences

Anatomy

Chromosomes, Human, Pair 17

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Shaw R J; Omar M M; Rokadiya S; Kogera F A; Lowe D; Hall G L; Woolgar J A; Homer J; Liloglou T; Field J K; Risk J M
Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer.
Verri Carla; Roz Luca; Conte Davide; Liloglou Triantafillos; Livio Anna; Vesin Aurelien; Fabbri Alessandra; Andriani Francesca; Brambilla Christian; Tavecchio Luca; Calarco Giuseppe; Calabrò Elisa; Mancini Andrea; Tosi Diego; Bossi Paolo; Field John K; Brambilla Elisabeth; Sozzi Gabriella;
Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.
Knight Lucy J; Burrage Joseph; Bujac Sarah R; Haggerty Carolyn; Graham Alexander; Gibson Neil J; Ellison Gillian; Growcott James W; Brooks A Nigel; Hughes Andrew M; Xinarianos George; Nikolaidis Georgios; Field John K; Liloglou Triantafillos
Epigenetic silencing of the endothelin-B receptor gene in non-small cell lung cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of John Field (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Shaw R J; Omar M M; Rokadiya S; Kogera F A; Lowe D; Hall G L; Woolgar J A; Homer J; Liloglou T; Field J K; Risk J M
Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer.
British journal of cancer 2009;101(1):139-44.
2009: Verri Carla; Roz Luca; Conte Davide; Liloglou Triantafillos; Livio Anna; Vesin Aurelien; Fabbri Alessandra; Andriani Francesca; Brambilla Christian; Tavecchio Luca; Calarco Giuseppe; Calabrò Elisa; Mancini Andrea; Tosi Diego; Bossi Paolo; Field John K; Brambilla Elisabeth; Sozzi Gabriella;
Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project.
American journal of respiratory and critical care medicine 2009;179(5):396-401.
2009: Knight Lucy J; Burrage Joseph; Bujac Sarah R; Haggerty Carolyn; Graham Alexander; Gibson Neil J; Ellison Gillian; Growcott James W; Brooks A Nigel; Hughes Andrew M; Xinarianos George; Nikolaidis Georgios; Field John K; Liloglou Triantafillos
Epigenetic silencing of the endothelin-B receptor gene in non-small cell lung cancer.
International journal of oncology 2009;34(2):465-71.
2009: Cairns David A; Barrett Jennifer H; Billingham Lucinda J; Stanley Anthea J; Xinarianos George; Field John K; Johnson Phillip J; Selby Peter J; Banks Rosamonde E
Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison.
Proteomics 2009;9(1):74-86.
2009: Daskalos Alexandros; Nikolaidis Georgios; Xinarianos George; Savvari Paraskevi; Cassidy Adrian; Zakopoulou Roubini; Kotsinas Athanasios; Gorgoulis Vassilis; Field John K; Liloglou Triantafillos
Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer.
International journal of cancer. Journal international du cancer 2009;124(1):81-7.
2008: Hung Rayjean J; Christiani David C; Risch Angela; Popanda Odilia; Haugen Aage; Zienolddiny Shan; Benhamou Simone; Bouchardy Christine; Lan Qing; Spitz Margaret R; Wichmann H-Erich; LeMarchand Loic; Vineis Paolo; Matullo Giuseppe; Kiyohara Chikako; Zhang Zuo-Feng; Pezeshki Benhnaz; Harris Curtis; Mechanic Leah; Seow Adeline; Ng Daniel P K; Szeszenia-Dabrowska Neonila; Zaridze David; Lissowska Jolanta; Rudnai Peter; Fabianova Eleonora; Mates Dana; Foretova Lenka; Janout Vladimir; Bencko Vladimir; Caporaso Neil; Chen Chu; Duell Eric J; Goodman Gary; Field John K; Houlston Richard S; Hong Yun-Chul; Landi Maria Teresa; Lazarus Philip; Muscat Joshua; McLaughlin John; Schwartz Ann G; Shen Hongbing; Stucker Isabelle; Tajima Kazuo; Matsuo Keitaro; Thun Michael; Yang Ping; Wiencke John; Andrew Angeline S; Monnier Stephanie; Boffetta Paolo; Brennan Paul
International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(11):3081-9.
2008: Smith Robert A; Field John K; Duffy Stephen W
A global approach to cancer-screening trials.
The lancet oncology 2008;9(10):908-9.
2008: Field John K
Lung cancer risk models come of age.
Cancer prevention research (Philadelphia, Pa.) 2008;1(4):226-8.
2008: Shivapurkar Narayan; Stastny Victor; Okumura Naoki; Girard Luc; Xie Yang; Prinsen Clemens; Thunnissen Frederik B; Wistuba Ignacio I; Czerniak Bogdan; Frenkel Eugene; Roth Jack A; Liloglou Triantafillos; Xinarianos George; Field John K; Minna John D; Gazdar Adi F
Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene.
Cancer research 2008;68(18):7448-56.
2008: Hall Gillian L; Shaw Richard J; Field E Anne; Rogers Simon N; Sutton David N; Woolgar Julia A; Lowe Derek; Liloglou Triantafillos; Field John K; Risk Janet M
p16 Promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(8):2174-9.
2008: Field J K; Duffy S W
Lung cancer screening: the way forward.
British journal of cancer 2008;99(4):557-62.
2008: Hung Rayjean J; McKay James D; Gaborieau Valerie; Boffetta Paolo; Hashibe Mia; Zaridze David; Mukeria Anush; Szeszenia-Dabrowska Neonilia; Lissowska Jolanta; Rudnai Peter; Fabianova Eleonora; Mates Dana; Bencko Vladimir; Foretova Lenka; Janout Vladimir; Chen Chu; Goodman Gary; Field John K; Liloglou Triantafillos; Xinarianos George; Cassidy Adrian; McLaughlin John; Liu Geoffrey; Narod Steven; Krokan Hans E; Skorpen Frank; Elvestad Maiken Bratt; Hveem Kristian; Vatten Lars; Linseisen Jakob; Clavel-Chapelon Françoise; Vineis Paolo; Bueno-de-Mesquita H Bas; Lund Eiliv; Martinez Carmen; Bingham Sheila; Rasmuson Torgny; Hainaut Pierre; Riboli Elio; Ahrens Wolfgang; Benhamou Simone; Lagiou Pagona; Trichopoulos Dimitrios; Holcátová Ivana; Merletti Franco; Kjaerheim Kristina; Agudo Antonio; Macfarlane Gary; Talamini Renato; Simonato Lorenzo; Lowry Ray; Conway David I; Znaor Ariana; Healy Claire; Zelenika Diana; Boland Anne; Delepine Marc; Foglio Mario; Lechner Doris; Matsuda Fumihiko; Blanche Helene; Gut Ivo; Heath Simon; Lathrop Mark; Brennan Paul
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.
Nature 2008;452(7187):633-7.
2008: Shaw Richard J; Hall Gillian L; Lowe Derek; Liloglou Triantafillos; Field John K; Sloan Phillip; Risk Janet M
The role of pyrosequencing in head and neck cancer epigenetics: correlation of quantitative methylation data with gene expression.
Archives of otolaryngology--head & neck surgery 2008;134(3):251-6.
2008: Cassidy A; Myles J P; van Tongeren M; Page R D; Liloglou T; Duffy S W; Field J K
The LLP risk model: an individual risk prediction model for lung cancer.
British journal of cancer 2008;98(2):270-6.
2008: Tanney Austin; Oliver Gavin R; Farztdinov Vadim; Kennedy Richard D; Mulligan Jude M; Fulton Ciaran E; Farragher Susan M; Field John K; Johnston Patrick G; Harkin D Paul; Proutski Vitali; Mulligan Karl A
Generation of a non-small cell lung cancer transcriptome microarray.
BMC medical genomics 2008;1():20.
2007: Shaw Richard J; Hall Gillian L; Woolgar Julia A; Lowe Derek; Rogers Simon N; Field John K; Liloglou Triantafillos; Risk Janet M
Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma.
The British journal of oral & maxillofacial surgery 2007;45(8):617-22.
2007: Shaw Richard J; Hall Gillian L; Lowe Derek; Bowers Naomi L; Liloglou Triantafillos; Field John K; Woolgar Julia A; Risk Janet M
CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology.
Oral oncology 2007;43(9):878-86.
2007: Gorlov Ivan P; Meyer Peter; Liloglou Triantafillos; Myles Jonathan; Boettger Melanie Barbara; Cassidy Adrian; Girard Luc; Minna John D; Fischer Reiner; Duffy Stephen; Spitz Margaret R; Haeussinger Karl; Kammerer Stefan; Cantor Charles; Dierkesmann Rainer; Field John K; Amos Christopher I
Seizure 6-like (SEZ6L) gene and risk for lung cancer.
Cancer research 2007;67(17):8406-11.
2007: Cassidy Adrian; 't Mannetje Andrea; van Tongeren Martie; Field John K; Zaridze David; Szeszenia-Dabrowska Neonila; Rudnai Peter; Lissowska Jolanta; Fabianova Eleonora; Mates Dana; Bencko Vladimir; Foretova Lenka; Janout Vladimir; Fevotte Joelle; Fletcher Tony; Brennan Paul; Boffetta Paolo
Occupational exposure to crystalline silica and risk of lung cancer: a multicenter case-control study in Europe.
Epidemiology (Cambridge, Mass.) 2007;18(1):36-43.
2007: Cassidy Adrian; Duffy Stephen W; Myles Jonathan P; Liloglou Triantafillos; Field John K
Lung cancer risk prediction: a tool for early detection.
International journal of cancer. Journal international du cancer 2007;120(1):1-6.
2006: Pateras Ioannis S; Apostolopoulou Kalliopi; Koutsami Marilena; Evangelou Kostas; Tsantoulis Petros; Liloglou Triantafillos; Nikolaidis Giorgos; Sigala Fragiska; Kittas Christos; Field John K; Kotsinas Athanassios; Gorgoulis Vassilis G
Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer.
International journal of cancer. Journal international du cancer 2006;119(11):2546-56.
2006: Ehrich Mathias; Field John K; Liloglou Triantafillos; Xinarianos George; Oeth Paul; Nelson Matthew R; Cantor Charles R; van den Boom Dirk
Cytosine methylation profiles as a molecular marker in non-small cell lung cancer.
Cancer research 2006;66(22):10911-8.
2006: Cassidy A; Myles J P; Duffy S W; Liloglou T; Field J K
Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives.
British journal of cancer 2006;95(9):1288-90.
2006: Xinarianos George; McRonald Fiona E; Risk Janet M; Bowers Naomi L; Nikolaidis Georgios; Field John K; Liloglou Triantafillos
Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer.
Human molecular genetics 2006;15(13):2038-44.
2006: Field J K; Smith R A; Duffy S W; Berg C D; van Klaveren R; Henschke C I; Carbone D; Postmus P E; Paci E; Hirsch F R; Mulshine J L
The Liverpool Statement 2005: priorities for the European Union/United States spiral computed tomography collaborative group.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(5):497-8.
2006: Cassidy Adrian; Myles Jonathan P; Liloglou Triantafillos; Duffy Stephen W; Field John K
Defining high-risk individuals in a population-based molecular-epidemiological study of lung cancer.
International journal of oncology 2006;28(5):1295-301.
2006: McRonald Fiona E; Liloglou Triantafillos; Xinarianos George; Hill Laura; Rowbottom Lynn; Langan Joanne E; Ellis Anthony; Shaw Joan M; Field John K; Risk Janet M
Down-regulation of the cytoglobin gene, located on 17q25, in tylosis with oesophageal cancer (TOC): evidence for trans-allele repression.
Human molecular genetics 2006;15(8):1271-7.
2006: Shaw R J; Liloglou T; Rogers S N; Brown J S; Vaughan E D; Lowe D; Field J K; Risk J M
Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
British journal of cancer 2006;94(4):561-8.
2006: Shaw Richard J; Akufo-Tetteh Emily K; Risk Janet M; Field John K; Liloglou Triantafillos
Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing.
Nucleic acids research 2006;34(11):e78.
2005: Field J K; Smith D L; Duffy S; Cassidy A
The Liverpool Lung Project research protocol.
International journal of oncology 2005;27(6):1633-45.
2005: Ehrich Mathias; Nelson Matthew R; Stanssens Patrick; Zabeau Marc; Liloglou Triantafillos; Xinarianos George; Cantor Charles R; Field John K; van den Boom Dirk
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(44):15785-90.
2005: Field J K; Liloglou T; Warrak S; Burger M; Becker E; Berlin K; Nimmrich I; Maier S
Methylation discriminators in NSCLC identified by a microarray based approach.
International journal of oncology 2005;27(1):105-11.
2004: Smith S L; Gugger M; Hoban P; Ratschiller D; Watson S G; Field J K; Betticher D C; Heighway J
S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas.
British journal of cancer 2004;91(8):1515-24.
2004: Dunn J R; Panutsopulos D; Shaw M W; Heighway J; Dormer R; Salmo E N; Watson S G; Field J K; Liloglou T
METH-2 silencing and promoter hypermethylation in NSCLC.
British journal of cancer 2004;91(6):1149-54.
2004: Shahabi M; Noori Daloii M R; Langan J E; Rowbottom L; Jahanzad E; Khoshbin E; Taghikhani M; Field J K; Risk J M
An investigation of the tylosis with oesophageal cancer (TOC) locus in Iranian patients with oesophageal squamous cell carcinoma.
International journal of oncology 2004;25(2):389-95.
2004: Langan Joanne E; Cole Charlotte G; Huckle Elisabeth J; Byrne Shaun; McRonald Fiona E; Rowbottom Lynn; Ellis Anthony; Shaw Joan M; Leigh Irene M; Kelsell David P; Dunham Ian; Field John K; Risk Janet M
Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (TOC) minimal region on 17q25 to 42.5 kb: sequencing does not identify the causative gene.
Human genetics 2004;114(6):534-40.
2004: Koh Theodore J; Field John K; Varro Andrea; Liloglou Triantafillos; Fielding Pat; Cui Guanglin; Houghton JeanMarie; Dockray Graham J; Wang Timothy C
Glycine-extended gastrin promotes the growth of lung cancer.
Cancer research 2004;64(1):196-201.
2004: Dolan Kevin; Morris Anthony I; Gosney John R; Field John K; Sutton Robert
Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease?
Journal of gastroenterology and hepatology 2004;19(1):24-30.
2003: Leversha M A; Fielding P; Watson S; Gosney J R; Field J K
Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays.
The Journal of pathology 2003;200(5):610-9.
2003: Dunn Julie R; Risk Janet M; Langan Joanne E; Marlee Damian; Ellis Anthony; Campbell Fiona; Watson Alastair J M; Field John K
Physical and transcript map of the minimally deleted region III on 17p implicated in the early development of Barrett's oesophageal adenocarcinoma.
Oncogene 2003;22(26):4134-42.
2003: Dolan Kevin; Morris Anthony I; Gosney John R; Field John K; Sutton Robert
Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrett's esophagus.
Journal of gastroenterology and hepatology 2003;18(6):683-9.
2003: Field J K; Brambilla C
Major conceptual change required to improve lung cancer: see a respiratory physician.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2003;21(4):565-6.
2003: Miyakis S; Liloglou T; Kearney S; Xinarianos G; Spandidos D A; Field J K
Absence of mutations in the VHL gene but frequent loss of heterozygosity at 3p25-26 in non-small cell lung carcinomas.
Lung cancer (Amsterdam, Netherlands) 2003;39(3):273-7.
2003: Scholes Andrea G M; Damato Bertil E; Nunn Janice; Hiscott Paul; Grierson Ian; Field John K
Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival.
Investigative ophthalmology & visual science 2003;44(3):1008-11.
2003: Sikkink Stephen K; Liloglou Triantafillos; Maloney Paul; Gosney John R; Field John K
In-depth analysis of molecular alterations within normal and tumour tissue from an entire bronchial tree.
International journal of oncology 2003;22(3):589-95.
2003: Nunn J; Nagini S; Risk J M; Prime W; Maloney P; Liloglou T; Jones A S; Rogers S R; Gosney J R; Woolgar J; Field J K
Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck.
Oral oncology 2003;39(2):115-29.
2003: Dolan K; Walker S J; Gosney J; Field J K; Sutton R
TP53 mutations in malignant and premalignant Barrett's esophagus.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2003;16(2):83-9.
2003: Field John K; Liloglou Triantafillos
Fluorescent microsatellite analysis in bronchial lavage as a potential diagnostic tool for lung cancer.
Methods in molecular medicine 2003;75():251-62.
2002: Mulshine James L; Smith Robert A; Field John K; Hirsch Fred R
Tobacco money: up in smoke?
Lancet 2002;360(9349):1979-80; author reply 1981.
2002: Smith S L; Damato B E; Scholes A G M; Nunn J; Field J K; Heighway J
Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival.
British journal of cancer 2002;87(11):1308-13.
2002: Heighway Jim; Knapp Teresa; Boyce Lenetta; Brennand Shelley; Field John K; Betticher Daniel C; Ratschiller Daniel; Gugger Mathias; Donovan Michael; Lasek Amy; Rickert Paula
Expression profiling of primary non-small cell lung cancer for target identification.
Oncogene 2002;21(50):7749-63.
2002: Hirsch Fred R; Bunn P A; Dmitrovsky E; Field J K; Franklin W A; Greenberg R E; Hansen H H; Henschke C I; Rigas James R; Smith R A; Toennesen P; Mulshine J L
IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001.
Lung cancer (Amsterdam, Netherlands) 2002;37(3):325-44.
2002: Risk Janet M; Evans Kathryn E; Jones Joanne; Langan Joanne E; Rowbottom Lyn; McRonald Fiona E; Mills Helen S; Ellis Anthony; Shaw Joan M; Leigh Irene M; Kelsell David P; Field John K
Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (TOC) locus.
Oncogene 2002;21(41):6395-402.
2002: Xinarianos George; Liloglou Triantafillos; Prime Wendy; Sourvinos George; Karachristos Andreas; Gosney John R; Spandidos Demetrios A; Field John K
p53 status correlates with the differential expression of the DNA mismatch repair protein MSH2 in non-small cell lung carcinoma.
International journal of cancer. Journal international du cancer 2002;101(3):248-52.
2002: Field J K; Youngson J H
The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2002;20(2):464-79.
2002: Langan J E; Rowbottom L; Liloglou T; Field J K; Risk J M
Sequencing of difficult templates containing poly(A/T) tracts: closure of sequence gaps.
BioTechniques 2002;33(2):276, 278, 280.
2002: Liloglou Triantafillos; Walters Matthew; Maloney Paul; Youngson Judith; Field John K
A T2517C polymorphism in the GSTM4 gene is associated with risk of developing lung cancer.
Lung cancer (Amsterdam, Netherlands) 2002;37(2):143-6.
2002: Field J K; Brambilla C; Caporaso N; Flahault A; Henschke C; Herman J; Hirsch F; Lachmann P; Lam S; Maier S; Montuenga L M; Mulshine J; Murphy M; Pullen J; Spitz M; Tockman M; Tyndale R; Wistuba I; Youngson J
Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations.
International journal of oncology 2002;21(2):369-73.
2002: Jones J; Field J K; Risk J M
A comparative guide to gene prediction tools for the bioinformatics amateur.
International journal of oncology 2002;20(4):697-705.
2001: Scholes A G; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato B E; Grierson I; Field J K
Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Investigative ophthalmology & visual science 2001;42(11):2472-7.
2001: Sourvinos G; Miyakis S; Liloglou T L; Field J K; Spandidos D A
Von Hippel-Lindau tumour suppressor gene is not involved in sporadic human breast cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2001;22(3):131-6.
2001: Kotsinas A; Gorgoulis V G; Zacharatos P; Mariatos G; Kokotas S; Liloglou T; Ikonomopoulos J; Zoumpourlis V; Kyroudi A; Field J K; Asimacopoulos P J; Kittas C
Additional characterization of a hexanucleotide polymorphic site in the first intron of human H-ras gene: comparative study of its alterations in non-small cell lung carcinomas and sporadic invasive breast carcinomas.
Cancer genetics and cytogenetics 2001;126(2):147-54.
2001: Liloglou T; Maloney P; Xinarianos G; Hulbert M; Walshaw M J; Gosney J R; Turnbull L; Field J K
Cancer-specific genomic instability in bronchial lavage: a molecular tool for lung cancer detection.
Cancer research 2001;61(4):1624-8.
2001: Kotsinas A; Gorgoulis V G; Zacharatos P; Liloglou T; Leonardou P; Bramis J; Troupis T G; Fotiadis C; Field J K; Kittas C
A new rare allele at the CGG repeat polymorphism in the first intron of human c-H-ras gene.
In vivo (Athens, Greece) 2001;15(1):105-8.
2001: Gorgoulis V G; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos P J; Kittas C; Field J K
Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
Cancer research 2001;61(2):538-49.
2001: Garinis G A; Gorgoulis V G; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis N G; Vassilakopoulos T; Vogiatzi T; Field J K; Kittas C
Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
The Journal of pathology 2001;193(1):55-65.
2000: Clayton S J; Scott F M; Walker J; Callaghan K; Haque K; Liloglou T; Xinarianos G; Shawcross S; Ceuppens P; Field J K; Fox J C
K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification.
Clinical chemistry 2000;46(12):1929-38.
2000: Gorgoulis V G; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field J K; Kittas C
Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
Cancer 2000;89(9):1933-45.
2000: Miyakis S; Sourvinos G; Liloglou T L; Stathopoulos G P; Field J K; Spandidos D A
The Von Hippel-Lindau (VHL) tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas.
International journal of cancer. Journal international du cancer 2000;88(3):503-5.
2000: Dunn J R; Garde J; Dolan K; Gosney J R; Oates B C; Watson A J; Fielding P; Field J K
The evolution of loss of heterozygosity on chromosome 17 during the progression to barrett's adenocarcinoma involves a unique combination of target sites in individual specimens.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(10):4033-42.
2000: Scully C; Field J K; Tanzawa H
Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications.
Oral oncology 2000;36(5):404-13.
2000: Xinarianos G; Liloglou T; Prime W; Maloney P; Callaghan J; Fielding P; Gosney J R; Field J K
hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas.
Cancer research 2000;60(15):4216-21.
2000: Athanasiou A; Gorgoulis V G; Zacharatos P; Mariatos G; Kotsinas A; Liloglou T; Karameris A; Foukas P; Manolis E N; Field J K; Kittas C
c-mos immunoreactivity is an indicator of good prognosis in lung cancer.
Histopathology 2000;37(1):45-54.
2000: Scully C; Field J K; Tanzawa H
Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations.
Oral oncology 2000;36(4):311-27.
2000: Gorgoulis V G; Mariatos1 G; Manolis E N; Zacharatos P; Kotsinas A; Liloglou T; Vogiatzi T; Tsagkaraki A; Kokotas S; Tsoli E; Alchanatis M; Sfikakis P P; Asimacopoulos P J; Field J K; Kittas C
Allelic imbalance at the 5q14 locus is associated with decreased apoptotic rate in non-small cell lung carcinomas (NSCLCs). Possible synergistic effect with p53 gene alterations on apoptosis.
Lung cancer (Amsterdam, Netherlands) 2000;28(3):211-24.
2000: Scully C; Field J K; Tanzawa H
Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control.
Oral oncology 2000;36(3):256-63.
2000: Dolan K; Garde J; Walker S J; Sutton R; Gosney J; Field J K
Histological and molecular mapping of adenocarcinoma of the oesophagus and gastroesophageal junction: loss of heterozygosity occurs in histologically normal epithelium in the oesophagus and stomach.
Oncology reports 2000;7(3):521-8.
2000: Xinarianos G; Scott F M; Liloglou T; Prime W; Turnbull L; Walshaw M; Field J K
Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease.
Lung cancer (Amsterdam, Netherlands) 2000;28(1):37-42.
2000: Gorgoulis V G; Zacharatos P; Kotsinas A; Mariatos G; Liloglou T; Vogiatzi T; Foukas P; Rassidakis G; Garinis G; Ioannides T; Zoumpourlis V; Bramis J; Michail P O; Asimacopoulos P J; Field J K; Kittas C
Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exert a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
Molecular medicine (Cambridge, Mass.) 2000;6(3):208-37.
2000: Mariatos G; Gorgoulis V G; Zacharatos P; Kotsinas A; Vogiatzi T; Rassidakis G; Foukas P; Liloglou T; Tiniakos D; Angelou N; Manolis E N; Veslemes M; Field J K; Kittas C
Expression of p16(INK4A) and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: relationship with tumor growth parameters and ploidy status.
International journal of cancer. Journal international du cancer 2000;89(2):133-41.
2000: Scott F M; Prime W; Walshaw M; Turnbull L; Field J K
Peptide amidating activity in human bronchoalveolar lavage fluid: relationship to lung cancer, inflammation and infection.
International journal of oncology 2000;16(2):327-32.
2000: Liloglou T; Maloney P; Xinarianos G; Fear S; Field J K
Sensitivity and limitations of high throughput fluorescent microsatellite analysis for the detection of allelic imbalance: application in lung tumors.
International journal of oncology 2000;16(1):5-14.
1999: Dolan K; Garde J; Walker S J; Sutton R; Gosney J; Field J K
LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus.
Human pathology 1999;30(12):1508-14.
1999: Fielding P; Turnbull L; Prime W; Walshaw M; Field J K
Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4048-52.
1999: Nunn J; Scholes A G; Liloglou T; Nagini S; Jones A S; Vaughan E D; Gosney J R; Rogers S; Fear S; Field J K
Fractional allele loss indicates distinct genetic populations in the development of squamous cell carcinoma of the head and neck (SCCHN).
Carcinogenesis 1999;20(12):2219-28.
1999: Xinarianos G; Scott F M; Liloglou T; Prime W; Callaghan J; Gosney J R; Field J K
Telomerase activity in non-small cell lung carcinomas correlates with smoking status.
International journal of oncology 1999;15(5):961-5.
1999: Karachristos A; Liloglou T; Field J K; Deligiorgi E; Kouskouni E; Spandidos D A
Microsatellite instability and p53 mutations in hepatocellular carcinoma.
Molecular cell biology research communications : MCBRC 1999;2(3):155-61.
1999: Risk J M; Ruhrberg C; Hennies H; Mills H S; Di Colandrea T; Evans K E; Ellis A; Watt F M; Bishop D T; Spurr N K; Stevens H P; Leigh I M; Reis A; Kelsell D P; Field J K
Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (TOC): the integration of genetic and physical maps of the TOC region on 17q25.
Genomics 1999;59(2):234-42.
1999: Field J K; Liloglou T; Xinarianos G; Prime W; Fielding P; Walshaw M J; Turnbull L
Genetic alterations in bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer.
Cancer research 1999;59(11):2690-5.
1999: Dunn J; Garde J; Dolan K; Gosney J R; Sutton R; Meltzer S J; Field J K
Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer.
Oncogene 1999;18(4):987-93.
1999: Risk J M; Mills H S; Garde J; Dunn J R; Evans K E; Hollstein M; Field J K
The tylosis esophageal cancer (TOC) locus: more than just a familial cancer gene.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 1999;12(3):173-6.
1998: Gorgoulis V G; Zacharatos P; Kotsinas A; Liloglou T; Kyroudi A; Veslemes M; Rassidakis A; Halazonetis T D; Field J K; Kittas C
Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
The American journal of pathology 1998;153(6):1749-65.
1998: von Brevern M; Hollstein M C; Risk J M; Garde J; Bennett W P; Harris C C; Muehlbauer K R; Field J K
Loss of heterozygosity in sporadic oesophageal tumors in the tylosis oesophageal cancer (TOC) gene region of chromosome 17q.
Oncogene 1998;17(16):2101-5.
1998: Dolan K; Garde J; Gosney J; Sissons M; Wright T; Kingsnorth A N; Walker S J; Sutton R; Meltzer S J; Field J K
Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.
British journal of cancer 1998;78(7):950-7.
1998: Scholes A G; Woolgar J A; Boyle M A; Brown J S; Vaughan E D; Hart C A; Jones A S; Field J K
Synchronous oral carcinomas: independent or common clonal origin?
Cancer research 1998;58(9):2003-6.
1998: Gosden C M; Liloglou T; Nunn J; Gardener D; Nickson P; Crampton J M; Field J K
The Knights of the Round Table hypothesis of tumour suppressor gene function--noble sacrifice or sexual dalliance: genes, including p53, BRCA1/2 and RB have evolved by horizontal and vertical transmission of mating factor genes and are involved in gametogenesis, implantation, development and tumourigenesis.
International journal of oncology 1998;12(1):5-35.
1997: Liloglou T; Scholes A G; Spandidos D A; Vaughan E D; Jones A S; Field J K
p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability.
Cancer research 1997;57(18):4070-4.
1997: Scholes A G; Liloglou T; Snijders P J; Hart C A; Jones A S; Woolgar J A; Vaughan E D; Walboomers J M; Field J K
p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck.
International journal of cancer. Journal international du cancer 1997;71(5):796-9.
1997: Rowley H; Helliwell T R; Jones A S; Roland N J; Field E A; Field J K
An immunohistochemical analysis of p53 protein expression in pre-malignant and malignant tissues of the oral cavity.
Clinical otolaryngology and allied sciences 1997;22(1):23-9.
1997: Field E A; Ellis A; Friedmann P S; Leigh I M; Field J K
Oral tylosis: a re-appraisal.
Oral oncology 1997;33(1):55-7.
1997: Liloglou T; Ross H; Prime W; Donnelly R J; Spandidos D A; Gosney J R; Field J K
p53 gene aberrations in non-small-cell lung carcinomas from a smoking population.
British journal of cancer 1997;75(8):1119-24.
1996: Field J K; Neville E M; Stewart M P; Swift A; Liloglou T; Risk J M; Ross H; Gosney J R; Donnelly R J
Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.
British journal of cancer 1996;74(12):1968-74.
1996: Hibbert S A; Field J K
Molecular basis of familial cleft lip and palate.
Oral diseases 1996;2(3):238-41.
1996: Field J K
Genomic instability in squamous cell carcinoma of the head and neck.
Anticancer research 1996;16(4C):2421-31.
1996: Kelsell D P; Risk J M; Leigh I M; Stevens H P; Ellis A; Hennies H C; Reis A; Weissenbach J; Bishop D T; Spurr N K; Field J K
Close mapping of the focal non-epidermolytic palmoplantar keratoderma (PPK) locus associated with oesophageal cancer (TOC).
Human molecular genetics 1996;5(6):857-60.
1996: Snijders P J; Scholes A G; Hart C A; Jones A S; Vaughan E D; Woolgar J A; Meijer C J; Walboomers J M; Field J K
Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck.
International journal of cancer. Journal international du cancer 1996;66(4):464-9.
1996: Scholes A G; Field J K
Genomic instability in head and neck cancer.
Current topics in pathology. Ergebnisse der Pathologie 1996;90():201-22.
1995: Field J K; Kiaris H; Risk J M; Tsiriyotis C; Adamson R; Zoumpourlis V; Rowley H; Taylor K; Whittaker J; Howard P
Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival.
British journal of cancer 1995;72(5):1180-8.
1995: Neville E M; Stewart M; Myskow M; Donnelly R J; Field J K
Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer.
Oncogene 1995;11(3):581-5.
1995: Kiaris H; Spandidos D A; Jones A S; Vaughan E D; Field J K
Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck.
British journal of cancer 1995;72(1):123-8.
1995: Rowley H; Jones A S; Field J K
Chromosome 18: a possible site for a tumour suppressor gene deletion in squamous cell carcinoma of the head and neck.
Clinical otolaryngology and allied sciences 1995;20(3):266-71.
1995: Swift A; Risk J M; Kingsnorth A N; Wright T A; Myskow M; Field J K
Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma.
British journal of cancer 1995;71(5):995-8.
1995: Field J K; Kiaris H; Howard P; Vaughan E D; Spandidos D A; Jones A S
Microsatellite instability in squamous cell carcinoma of the head and neck.
British journal of cancer 1995;71(5):1065-9.
1995: Jones A S; Morar P; Phillips D E; Field J K; Husband D; Helliwell T R
Second primary tumors in patients with head and neck squamous cell carcinoma.
Cancer 1995;75(6):1343-53.
1995: Jones A S; McRae R D; Phillips D E; Hamilton J; Field J K; Husband D
The treatment of node negative squamous cell carcinoma of the postcricoid region.
The Journal of laryngology and otology 1995;109(2):114-9.
1995: Field J K
The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma.
Journal of the Royal Society of Medicine 1995;88(1):35P-39P.
1995: Scarnecchia Suellyn; Field Julie Kunce
Judging girls: decision making in parental consent to abortion cases.
Michigan journal of gender & law 1995;3(41):75-123.
1994: Jones A S; Wilde A; McRae R D; Phillips D E; Field J K; Husband D G
The treatment of early squamous cell carcinoma of the piriform fossa.
Clinical otolaryngology and allied sciences 1994;19(6):485-90.
1994: Risk J M; Field E A; Field J K; Whittaker J; Fryer A; Ellis A; Shaw J M; Friedmann P S; Bishop D T; Bodmer J
Tylosis oesophageal cancer mapped.
Nature genetics 1994;8(4):319-21.
1994: Kinsella A R; Bowie G L; Field J K; Jones A S
Expression of the cell-cell adhesion molecule E-cadherin in tongue carcinoma cell lines.
The Journal of laryngology and otology 1994;108(11):957-61.
1994: Adamson R; Jones A S; Field J K
Loss of heterozygosity studies on chromosome 17 in head and neck cancer using microsatellite markers.
Oncogene 1994;9(7):2077-82.
1994: Porter M J; Field J K; Lee J C; Leung S F; Lo D; Van Hasselt C A
Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese.
Anticancer research 1994;14(3B):1357-60.
1994: Jones A S; Roland N J; Field J K; Phillips D E
The level of cervical lymph node metastases: their prognostic relevance and relationship with head and neck squamous carcinoma primary sites.
Clinical otolaryngology and allied sciences 1994;19(1):63-9.
1994: Porter M J; Field J K; Leung S F; Lo D; Lee J C; Spandidos D A; van Hasselt C A
The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry.
Acta oto-laryngologica 1994;114(1):105-9.
1994: Field J K; Zoumpourlis V; Spandidos D A; Jones A S
p53 expression and mutations in squamous cell carcinoma of the head and neck: expression correlates with the patients' use of tobacco and alcohol.
Cancer detection and prevention 1994;18(3):197-208.
1994: Ellis A; Field J K; Field E A; Friedmann P S; Fryer A; Howard P; Leigh I M; Risk J; Shaw J M; Whittaker J
Tylosis associated with carcinoma of the oesophagus and oral leukoplakia in a large Liverpool family--a review of six generations.
European journal of cancer. Part B, Oral oncology 1994;30B(2):102-12.
1993: Field J K; Pavelic Z P; Spandidos D A; Stambrook P J; Jones A S; Gluckman J L
The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck.
Archives of otolaryngology--head & neck surgery 1993;119(10):1118-22.
1993: Jones A S; Phillips D E; Cook J A; Field J K; Gati I
Non-squamous malignancy in lymph nodes: the occult primary.
Clinical otolaryngology and allied sciences 1993;18(4):311-6.
1993: Bowie G L; Caslin A W; Roland N J; Field J K; Jones A S; Kinsella A R
Expression of the cell-cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck.
Clinical otolaryngology and allied sciences 1993;18(3):196-201.
1993: Gosney J R; Butt S A; Gosney M A; Field J K
Exposure to cigarette smoke and expression of the protein encoded by the p53 gene in bronchial carcinoma.
Annals of the New York Academy of Sciences 1993;686():243-7; discussion 247-8.
1993: Spandidos D A; Liloglou T; Field J K
Prognostic significance of oncogenes and tumor suppressor genes in human malignancy.
Stem cells (Dayton, Ohio) 1993;11(3):194-8.
1992: Jones A S; Phillips D E; Field J K
A phase II study of cisplatinum versus cisplatinum + nifedipine in end-stage carcinoma of the head and neck.
Clinical otolaryngology and allied sciences 1992;17(6):501-4.
1992: Owens W; Field J K; Howard P J; Stell P M
Multiple cytogenetic aberrations in squamous cell carcinomas of the head and neck.
European journal of cancer. Part B, Oral oncology 1992;28B(1):17-21.
1992: Field J K
Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck.
European journal of cancer. Part B, Oral oncology 1992;28B(1):67-76.
1992: Field J K; Spandidos D A; Yiagnisis M; Gosney J R; Papadimitriou K; Stell P M
C-erbB-2 expression in squamous cell carcinoma of the head and neck.
Anticancer research 1992;12(3):613-9.
1992: Field J K; Yiagnisis M; Spandidos D A; Gosney J R; Papadimitriou K; Vaughan E D; Stell P M
Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1992;18(2):168-76.
1992: Field J K; Spandidos D A; Stell P M
Overexpression of p53 gene in head-and-neck cancer, linked with heavy smoking and drinking.
Lancet 1992;339(8791):502-3.
1992: Spandidos D A; Karaiossifidi H; Malliri A; Linardopoulos S; Vassilaros S; Tsikkinis A; Field J K
Expression of ras Rb1 and p53 proteins in human breast cancer.
Anticancer research 1992;12(1):81-9.
1991: Field J K; Spandidos D A; Malliri A; Gosney J R; Yiagnisis M; Stell P M
Elevated P53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck.
British journal of cancer 1991;64(3):573-7.
1991: Koutselini H; Malliri A; Field J K; Spandidos D A
p53 expression in cytologic specimens from benign and malignant breast lesions.
Anticancer research 1991;11(4):1415-9.
1991: Arvanitis D; Malliri A; Antoniou D; Linardopoulos S; Field J K; Spandidos D A
Ras p21 expression in brain tumors: elevated expression in malignant astrocytomas and glioblastomas multiforme.
In vivo (Athens, Greece) 1991;5(4):317-21.
1991: Spandidos D A; Karayiannis M; Yiagnisis M; Papadimitriou K; Field J K
Immunohistochemical analysis of the expression of the c-myc oncoprotein in human stomach cancers.
Digestion 1991;50(3-4):127-34.
1990: Spandidos D A; Kaloterakis A; Yiagnisis M; Varatsos A; Field J K
Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma.
Anticancer research 1990;10(6):1619-25.
1990: Karayiannis M; Yiagnisis M; Papadimitriou K; Field J K; Spandidos D A
Evaluation of the ras and myc oncoproteins in benign gastric lesions.
Anticancer research 1990;10(5A):1127-33.
1990: Spandidos D A; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos A M; Roussos C; Field J K
Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
Anticancer research 1990;10(5A):1105-14.
1990: Gosney J R; Field J K; Gosney M A; Lye M D; Spandidos D A; Butt S A
c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types.
Anticancer research 1990;10(3):623-8.
1990: Koutselini H; Kappatou G; Yiagnisis M; Field J K; Spandidos D A
Immunocytochemical study of RAS oncoprotein in cytologic specimens of primary lung tumours.
Anticancer research 1990;10(3):597-603.
1990: Field J K; Spandidos D A
The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review).
Anticancer research 1990;10(1):1-22.
1989: Field J K; Spandidos D A; Stell P M; Vaughan E D; Evan G I; Moore J P
Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma.
Oncogene 1989;4(12):1463-8.
1989: Spandidos D A; Yiagnisis M; Papadimitriou K; Field J K
ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
Anticancer research 1989;9(5):1385-93.
1989: Spandidos D A; Field J K; Agnantis N J; Evan G I; Moore J P
High levels of c-myc protein in human breast tumours determined by a sensitive ELISA technique.
Anticancer research 1989;9(4):821-6.
1989: Field E A; Field J K; Martin M V
Does Candida have a role in oral epithelial neoplasia?
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1989;27(5):277-94.
1988: Martin M V; Dunn H M; Field E A; Field J K; Hibbert S A; McGowan P; Wardle I
A physical and microbiological evaluation of the re-use of non-sterile gloves.
British dental journal 1988;165(9):321-4.
1988: Field E A; Field J K; Martin M V
Time, steam, temperature (TST) control indicators to measure essential sterilisation criteria for autoclaves in general dental practice and the community dental service.
British dental journal 1988;164(6):183-6.
1987: Field J K; Spandidos D A
Expression of oncogenes in human tumours with special reference to the head and neck region.
Journal of oral pathology 1987;16(3):97-107.
1986: Field J K; Lamothe A; Spandidos D A
Clinical relevance of oncogene expression in head and neck tumours.
Anticancer research 1986;6(4):595-600.
1985: Spandidos D A; Lamothe A; Field J K
Multiple transcriptional activation of cellular oncogenes in human head and neck solid tumours.
Anticancer research 1985;5(2):221-4.
1984: Denney N W; Field J K; Quadagno D
Sex differences in sexual needs and desires.
Archives of sexual behavior 1984;13(3):233-45.
1983: Page M J; Field J K; Everett N P; Green C D
Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7.
Cancer research 1983;43(3):1244-50.
1982: Green S; Field J K; Green C D; Beynon R J
A microcomputer program for analysis of nucleic acid hybridization data.
Nucleic acids research 1982;10(4):1411-20.
1978: Page M J; Field J K; Green C D
The response to hormones and anti-hormones of human breast tumour cells grown in continuous culture [proceedings]
Biochemical Society transactions 1978;6(6):1318-9.
1976: Field J K; Cunningham E P
A further study of the inheritance of racing performance in thoroughbred horses.
The Journal of heredity 1976;67(4):247-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

John Field

Research Profile (preview)

Disorders

Chemicals & Drugs

Genes & Molecular Sequences

Anatomy

Physiology

Procedures

Activities & Behaviors

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of John Field (preview)

All Publications